Neuberger Berman Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Buy
38,120
+7,070
+23% +$42.3K ﹤0.01% 1997
2025
Q4
$216K Buy
31,050
+50
+0.2% +$329 ﹤0.01% 1928
2025
Q3
$200K Hold
31,000
﹤0.01% 1916
2025
Q2
$206K Sell
31,000
-30,709
-50% -$158K ﹤0.01% 1880
2025
Q1
$400K Buy
61,709
+150
+0.2% +$1.08K ﹤0.01% 1605
2024
Q4
$497K Hold
61,559
﹤0.01% 1527
2024
Q3
$503K Hold
61,559
﹤0.01% 1523
2024
Q2
$429K Buy
61,559
+18,000
+41% +$136K ﹤0.01% 1533
2024
Q1
$462K Sell
43,559
-51,900
-54% -$454K ﹤0.01% 1531
2023
Q4
$767K Sell
95,459
-10,040
-10% -$73.1K ﹤0.01% 1358
2023
Q3
$869K Hold
105,499
﹤0.01% 1298
2023
Q2
$844K Sell
105,499
-17,097
-14% -$126K ﹤0.01% 1295
2023
Q1
$993K Buy
122,596
+1,651
+1% +$13.3K ﹤0.01% 1254
2022
Q4
$759K Sell
120,945
-19,095
-14% -$133K ﹤0.01% 1323
2022
Q3
$976K Buy
140,040
+36,370
+35% +$253K ﹤0.01% 1266
2022
Q2
$866K Sell
103,670
-37,709
-27% -$527K ﹤0.01% 1326
2022
Q1
$3.23M Buy
141,379
+42,768
+43% +$1.05M ﹤0.01% 1068
2021
Q4
$2.72M Sell
98,611
-1,118
-1% -$29.9K ﹤0.01% 1116
2021
Q3
$2.78M Sell
99,729
-65,066
-39% -$1.85M ﹤0.01% 1096
2021
Q2
$4.84M Sell
164,795
-20,939
-11% -$634K ﹤0.01% 965
2021
Q1
$5.9M Buy
185,734
+68,227
+58% +$2M 0.01% 920
2020
Q4
$2.44M Buy
117,507
+31,312
+36% +$584K ﹤0.01% 1074
2020
Q3
$1.34M Sell
86,195
-31,522
-27% -$543K ﹤0.01% 1140
2020
Q2
$2.15M Buy
117,717
+21,814
+23% +$384K ﹤0.01% 990
2020
Q1
$1.47M Sell
95,903
-113,161
-54% -$2.73M ﹤0.01% 1011
2019
Q4
$6.26M Buy
+209,064
New +$5.43M 0.01% 824
2019
Q3
Sell
-20,131
Closed -$508K 1538
2019
Q2
$508K Buy
20,131
+2,779
+16% +$66K ﹤0.01% 1292
2019
Q1
$429K Buy
17,352
+605
+4% +$14.4K ﹤0.01% 1292
2018
Q4
$311K Sell
16,747
-5,831
-26% -$139K ﹤0.01% 1353
2018
Q3
$580K Buy
22,578
+28
+0.1% +$641 ﹤0.01% 1292
2018
Q2
$525K Buy
22,550
+2,964
+15% +$61.3K ﹤0.01% 1386
2018
Q1
$312K Buy
+19,586
New +$365K ﹤0.01% 1460
2016
Q2
Sell
-8,063
Closed -$212K 1538
2016
Q1
$212K Sell
8,063
-3,049
-27% -$225K ﹤0.01% 1427
2015
Q4
$1.13M Sell
11,112
-6,091
-35% -$684K ﹤0.01% 1101
2015
Q3
$3.07M Sell
17,203
-6,177
-26% -$1.44M ﹤0.01% 965
2015
Q2
$5.19M Sell
23,380
-1,344
-5% -$298K 0.01% 932
2015
Q1
$4.91M Sell
24,724
-238
-1% -$42.2K 0.01% 943
2014
Q4
$3.57M Buy
24,962
+2,737
+12% +$368K ﹤0.01% 989
2014
Q3
$2.92M Sell
22,225
-1,080
-5% -$129K ﹤0.01% 1050
2014
Q2
$2.94M Sell
23,305
-3,436
-13% -$438K ﹤0.01% 1057
2014
Q1
$3.52M Sell
26,741
-552
-2% -$75.5K ﹤0.01% 984
2013
Q4
$3.2M Buy
27,293
+2,669
+11% +$292K ﹤0.01% 967
2013
Q3
$2.57M Buy
24,624
+311
+1% +$30.3K ﹤0.01% 993
2013
Q2
$2.09M Buy
+24,313
New +$1.92M ﹤0.01% 1046

Other funds holding BHC

Neuberger Berman Group's BHC Position: Q1 2026 in Review

Neuberger Berman Group increased its Bausch Health (BHC) stake by 23% in Q1 2026, buying an estimated $42.3K and bringing the position to 38,120 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

Neuberger Berman Group first reported a position in BHC in Q2 2013 and has held it in 44 quarters since. The position peaked at $6.26M in Q4 2019. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Neuberger Berman Group held 38,120 shares of Bausch Health worth $206K as of Q1 2026.
  • Neuberger Berman Group bought 7,070 Bausch Health shares in Q1 2026, an estimated $42.3K.
  • Bausch Health made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1997 holding.
  • Neuberger Berman Group first reported a position in Bausch Health in Q2 2013 and has held it in 44 quarters since.
  • Neuberger Berman Group's Bausch Health position peaked at $6.26M in Q4 2019.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.